US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

3  4  5  6    8    10  11  12  
PharmaPoint: Irritable Bowel Syndrome - Current and Future Players
12/31/2014 | published by: GlobalData
... with in-depth analysis on the companies in the rapidly growing Irritable Bowel Syndrome Market. The report identifies and analyses the key companies shaping and driving the global Irritable Bowel Syndrome market. The report provides insight ...  |  read more...
USD 2,995
PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies ...  |  read more...
USD 4,995
Linzess (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Lotronex (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Ibodutant (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies ...  |  read more...
USD 4,995
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Opioid-Induced Constipation (OIC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
... habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional gastrointestinal disorder. IBS is one of the most common gastrointestinal disorders; moreover, it has a ...  |  read more...
USD 3,995
Emesis (Vomiting) - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Emesis (Vomiting), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ulcerative Colitis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top ulcerative colitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Ulcerative Colitis Partnering 2009-2014 provides understanding and access to the ulcerative colitis partnering deals ...  |  read more...
USD 695
Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Nausea -API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Global Irritable Bowel Syndrome Market 2015-2019
11/19/2014 | published by: TechNavio - Infiniti Research Ltd.
... a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. ...  |  read more...
USD 2,500
Acid Indigestion / Heartburn/ Pyrosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Helicobacter Pylori Infections Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Global Gastrointestinal Infrared Therapy Device Industry
11/2/2014 | published by: 9Dimen Research
... of Gastrointestinal Infrared Therapy Device industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Gastrointestinal Infrared Therapy ...  |  read more...
USD 2,850
Inflammatory Bowel Disease - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Global and Chinese Gastrointestinal Biopsy Forceps Industry, 2009-2019 Market Research Report
9/17/2014 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Gastrointestinal Biopsy Forceps manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the ...  |  read more...
USD 2,800
Adult Diaper Market in Japan 2015-2019
12/24/2014 | published by: TechNavio - Infiniti Research Ltd.
... manner. They require to be replaced after usage. Baby diapers, underpants, and sanitary napkins are different forms of diapers. Adult diapers are usually used by people aged above 55 years. These people suffer from problems ...  |  read more...
USD 2,500
Global and Chinese Gastric Lavage Sets Industry, 2009-2019 Market Research Report
9/17/2014 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Gastric Lavage Sets manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the ...  |  read more...
USD 2,800
Digestive Remedies - Tunisia
9/12/2014 | published by: Euromonitor International
... consumer foodservice, with sandwiches from street stalls/kiosks becoming an increasingly popular lunch option. However, many street stalls/kiosks operate in unsanitary conditions, partly due to the warm climate in Tunisia, increasing the risk of food poisoning. ...  |  read more...
USD 900
3  4  5  6    8    10  11  12